Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
Two types of HAV vaccines are currently available internationally:1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.The classification of Hepatitis A Vaccine includes Inactivated Vaccine, Live Attenuated Vaccine, and the sales proportion of Inactivated Vaccine in 2017 is about 70.8%, and the proportion is increasing trend from 2013 to 2018.Inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
This report elaborates on the current development of the Hepatitis A Vaccine industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Kaketsuken
Changchun Institute of Biological
ChangSheng
Sanofi
Convac
Merck
Sinovac
GSK
IMBCA
Zhejiang Pukang
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Inactivated Vaccine
Live Attenuated Vaccine
Application:
Government Institution
Private Sector
Other
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Hepatitis A Vaccine Industry Overview
-
1.1.1 Hepatitis A Vaccine Market Scope and Market Segments
-
1.1.2 Hepatitis A Vaccine Industry Characteristics
-
1.1.3 Global and China Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Hepatitis A Vaccine Production Value and Growth Rate (2017-2028)
-
1.2 Global Hepatitis A Vaccine Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Inactivated Vaccine
-
1.2.2 Live Attenuated Vaccine
-
1.3 Global Hepatitis A Vaccine Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Government Institution
-
1.3.2 Private Sector
-
1.3.3 Other
-
1.4 Market Analysis by Region
-
1.4.1 North America Hepatitis A Vaccine Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Hepatitis A Vaccine Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Hepatitis A Vaccine Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Hepatitis A Vaccine Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Hepatitis A Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Hepatitis A Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Hepatitis A Vaccine Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Hepatitis A Vaccine Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Hepatitis A Vaccine Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Hepatitis A Vaccine Industry Porter's Five Forces Model Analysis
-
2.2.3 Hepatitis A Vaccine Industry PEST Analysis
-
2.3 Hepatitis A Vaccine Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Hepatitis A Vaccine Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Hepatitis A Vaccine Industry
Chapter 3 Global and China Hepatitis A Vaccine Market, by Manufacturer
-
3.1 Global and China Hepatitis A Vaccine Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Hepatitis A Vaccine Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Hepatitis A Vaccine Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Hepatitis A Vaccine Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Hepatitis A Vaccine Market Top 3 Players
Chapter 4 Global and China Hepatitis A Vaccine Market, by Type (2017-2028)
-
4.1 Hepatitis A Vaccine Market Trend, by Type
-
4.2 Global Hepatitis A Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Hepatitis A Vaccine Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Hepatitis A Vaccine Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Hepatitis A Vaccine Price Trend, by Type (2017-2028)
-
4.3 China Hepatitis A Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Hepatitis A Vaccine Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Hepatitis A Vaccine Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Hepatitis A Vaccine Price Trend, by Type (2017-2028)
Chapter 5 Global and China Hepatitis A Vaccine Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Hepatitis A Vaccine Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Hepatitis A Vaccine Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Hepatitis A Vaccine Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Hepatitis A Vaccine Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Hepatitis A Vaccine Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Hepatitis A Vaccine Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Hepatitis A Vaccine Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Hepatitis A Vaccine Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Hepatitis A Vaccine Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Hepatitis A Vaccine Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Hepatitis A Vaccine Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Hepatitis A Vaccine Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Hepatitis A Vaccine Market Analysis
-
7.1 North America Hepatitis A Vaccine Market, by Type
-
7.2 North America Hepatitis A Vaccine Market, by Application
-
7.3 North America Hepatitis A Vaccine Market Analysis and Forecast, by Country
-
7.3.1 United States Hepatitis A Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Hepatitis A Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Hepatitis A Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Hepatitis A Vaccine Market Analysis
-
8.1 Europe Hepatitis A Vaccine Market, by Type
-
8.2 Europe Hepatitis A Vaccine Market, by Application
-
8.3 Europe Hepatitis A Vaccine Market Analysis and Forecast, by Country
-
8.3.1 Germany Hepatitis A Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Hepatitis A Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Hepatitis A Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Hepatitis A Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Hepatitis A Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Hepatitis A Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Hepatitis A Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Hepatitis A Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Hepatitis A Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Hepatitis A Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Hepatitis A Vaccine Market Analysis
-
9.1 APAC Hepatitis A Vaccine Market, by Type
-
9.2 APAC Hepatitis A Vaccine Market, by Application
-
9.3 APAC Hepatitis A Vaccine Market Analysis and Forecast, by Country
-
9.3.1 China Hepatitis A Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Hepatitis A Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Hepatitis A Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Hepatitis A Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Hepatitis A Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Hepatitis A Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Hepatitis A Vaccine Market Analysis
-
10.1 Latin America, Middle East and Africa Hepatitis A Vaccine Market, by Type
-
10.2 Latin America, Middle East and Africa Hepatitis A Vaccine Market, by Application
-
10.3 Latin America, Middle East and Africa Hepatitis A Vaccine Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Hepatitis A Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Hepatitis A Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Hepatitis A Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Hepatitis A Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Hepatitis A Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Hepatitis A Vaccine Company Profiles
-
11.1 Kaketsuken
-
11.1.1 Kaketsuken Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Kaketsuken Hepatitis A Vaccine Product Profiles, Application and Specification
-
11.1.3 Kaketsuken Hepatitis A Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Changchun Institute of Biological
-
11.2.1 Changchun Institute of Biological Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Changchun Institute of Biological Hepatitis A Vaccine Product Profiles, Application and Specification
-
11.2.3 Changchun Institute of Biological Hepatitis A Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 ChangSheng
-
11.3.1 ChangSheng Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 ChangSheng Hepatitis A Vaccine Product Profiles, Application and Specification
-
11.3.3 ChangSheng Hepatitis A Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Sanofi
-
11.4.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Sanofi Hepatitis A Vaccine Product Profiles, Application and Specification
-
11.4.3 Sanofi Hepatitis A Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Convac
-
11.5.1 Convac Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Convac Hepatitis A Vaccine Product Profiles, Application and Specification
-
11.5.3 Convac Hepatitis A Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Merck
-
11.6.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Merck Hepatitis A Vaccine Product Profiles, Application and Specification
-
11.6.3 Merck Hepatitis A Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Sinovac
-
11.7.1 Sinovac Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Sinovac Hepatitis A Vaccine Product Profiles, Application and Specification
-
11.7.3 Sinovac Hepatitis A Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 GSK
-
11.8.1 GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 GSK Hepatitis A Vaccine Product Profiles, Application and Specification
-
11.8.3 GSK Hepatitis A Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 IMBCA
-
11.9.1 IMBCA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 IMBCA Hepatitis A Vaccine Product Profiles, Application and Specification
-
11.9.3 IMBCA Hepatitis A Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Zhejiang Pukang
-
11.10.1 Zhejiang Pukang Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Zhejiang Pukang Hepatitis A Vaccine Product Profiles, Application and Specification
-
11.10.3 Zhejiang Pukang Hepatitis A Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Hepatitis A Vaccine Industry Investment Prospect and Risk Assessment
-
12.1 Hepatitis A Vaccine Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Hepatitis A Vaccine Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure China Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Global Hepatitis A Vaccine Production Value and Growth Rate (2017-2028)
-
Figure China Hepatitis A Vaccine Production Value and Growth Rate (2017-2028)
-
Figure Global Hepatitis A Vaccine Market Size and Growth Rate of Inactivated Vaccine (2017-2028)
-
Figure Global Hepatitis A Vaccine Market Size and Growth Rate of Live Attenuated Vaccine (2017-2028)
-
Figure Global Hepatitis A Vaccine Market Size and Growth Rate of Government Institution (2017-2028)
-
Figure Global Hepatitis A Vaccine Market Size and Growth Rate of Private Sector (2017-2028)
-
Figure Global Hepatitis A Vaccine Market Size and Growth Rate of Other (2017-2028)
-
Figure North America Hepatitis A Vaccine Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Hepatitis A Vaccine Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Hepatitis A Vaccine Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Hepatitis A Vaccine Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Hepatitis A Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Hepatitis A Vaccine Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Hepatitis A Vaccine Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Hepatitis A Vaccine Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Hepatitis A Vaccine Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Hepatitis A Vaccine Market Share, by Manufacturer in 2021
-
Figure Global and China Hepatitis A Vaccine Market Share, by Manufacturer in 2022
-
Table Global Hepatitis A Vaccine Sales Volume, by Type (2017-2028)
-
Table Global Hepatitis A Vaccine Sales Volume Share, by Type (2017-2028)
-
Figure Global Hepatitis A Vaccine Sales Volume Share, by Type (2017-2028)
-
Table Global Hepatitis A Vaccine Sales Value, by Type (2017-2028)
-
Table Global Hepatitis A Vaccine Sales Value Share, by Type (2017-2028)
-
Figure Global Hepatitis A Vaccine Price Trend, by Type (2017-2028)
-
Table China Hepatitis A Vaccine Sales Volume, by Type (2017-2028)
-
Table China Hepatitis A Vaccine Sales Volume Share, by Type (2017-2028)
-
Figure China Hepatitis A Vaccine Sales Volume Share, by Type (2017-2028)
-
Table China Hepatitis A Vaccine Sales Value, by Type (2017-2028)
-
Table China Hepatitis A Vaccine Sales Value Share, by Type (2017-2028)
-
Figure China Hepatitis A Vaccine Price Trend, by Type (2017-2028)
-
Table Global Hepatitis A Vaccine Sales Volume, by Application (2017-2028)
-
Table Global Hepatitis A Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure Global Hepatitis A Vaccine Sales Volume Share, by Application (2017-2028)
-
Table Global Hepatitis A Vaccine Sales Value, by Application (2017-2028)
-
Table Global Hepatitis A Vaccine Sales Value Share, by Application (2017-2028)
-
Figure Global Hepatitis A Vaccine Sales Value Share, by Application (2017-2028)
-
Table China Hepatitis A Vaccine Sales Volume, by Application (2017-2028)
-
Table China Hepatitis A Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure China Hepatitis A Vaccine Sales Volume Share, by Application (2017-2028)
-
Table China Hepatitis A Vaccine Sales Value, by Application (2017-2028)
-
Table China Hepatitis A Vaccine Sales Value Share, by Application (2017-2028)
-
Figure China Hepatitis A Vaccine Sales Value Share, by Application (2017-2028)
-
Figure China Hepatitis A Vaccine Production, Import, Consumption and Export (2017-2022)
-
Figure North America Hepatitis A Vaccine Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Hepatitis A Vaccine Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Hepatitis A Vaccine Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Hepatitis A Vaccine Production, Import, Consumption and Export (2017-2022)
-
Table North America Hepatitis A Vaccine Sales Volume, by Type (2017-2028)
-
Table North America Hepatitis A Vaccine Sales Volume Share, by Type (2017-2028)
-
Figure North America Hepatitis A Vaccine Sales Volume Share, by Type (2017-2028)
-
Table North America Hepatitis A Vaccine Sales Volume, by Application (2017-2028)
-
Table North America Hepatitis A Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure North America Hepatitis A Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure United States Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure United States Hepatitis A Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Canada Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Hepatitis A Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Hepatitis A Vaccine Sales Value and Growth Rate (2017-2028)
-
Table Europe Hepatitis A Vaccine Sales Volume, by Type (2017-2028)
-
Table Europe Hepatitis A Vaccine Sales Volume Share, by Type (2017-2028)
-
Figure Europe Hepatitis A Vaccine Sales Volume Share, by Type (2017-2028)
-
Table Europe Hepatitis A Vaccine Sales Volume, by Application (2017-2028)
-
Table Europe Hepatitis A Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure Europe Hepatitis A Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure Germany Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Hepatitis A Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure UK Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure UK Hepatitis A Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure France Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure France Hepatitis A Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Italy Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Hepatitis A Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Hepatitis A Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Spain Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Hepatitis A Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Hepatitis A Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Poland Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Hepatitis A Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Russia Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Hepatitis A Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Hepatitis A Vaccine Sales Value and Growth Rate (2017-2028)
-
Table APAC Hepatitis A Vaccine Sales Volume, by Type (2017-2028)
-
Table APAC Hepatitis A Vaccine Sales Volume Share, by Type (2017-2028)
-
Figure APAC Hepatitis A Vaccine Sales Volume Share, by Type (2017-2028)
-
Table APAC Hepatitis A Vaccine Sales Volume, by Application (2017-2028)
-
Table APAC Hepatitis A Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure APAC Hepatitis A Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure China Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure China Hepatitis A Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Japan Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Hepatitis A Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Hepatitis A Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure India Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure India Hepatitis A Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Hepatitis A Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Hepatitis A Vaccine Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Hepatitis A Vaccine Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Hepatitis A Vaccine Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Hepatitis A Vaccine Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Hepatitis A Vaccine Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Hepatitis A Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Hepatitis A Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Hepatitis A Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Hepatitis A Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Hepatitis A Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Hepatitis A Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Hepatitis A Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Hepatitis A Vaccine Sales Value and Growth Rate (2017-2028)
-
Table Kaketsuken Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Kaketsuken Product Profiles, Application and Specification
-
Table Kaketsuken Hepatitis A Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Changchun Institute of Biological Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Changchun Institute of Biological Product Profiles, Application and Specification
-
Table Changchun Institute of Biological Hepatitis A Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table ChangSheng Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table ChangSheng Product Profiles, Application and Specification
-
Table ChangSheng Hepatitis A Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi Product Profiles, Application and Specification
-
Table Sanofi Hepatitis A Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Convac Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Convac Product Profiles, Application and Specification
-
Table Convac Hepatitis A Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Merck Product Profiles, Application and Specification
-
Table Merck Hepatitis A Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sinovac Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sinovac Product Profiles, Application and Specification
-
Table Sinovac Hepatitis A Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table GSK Product Profiles, Application and Specification
-
Table GSK Hepatitis A Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table IMBCA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table IMBCA Product Profiles, Application and Specification
-
Table IMBCA Hepatitis A Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Zhejiang Pukang Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Zhejiang Pukang Product Profiles, Application and Specification
-
Table Zhejiang Pukang Hepatitis A Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
